OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients Seite 1

OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans
ROCHESTER, Mich., OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, today announced that it has signed an agreement with one of the top 5 pharmaceutical companies to drive a new patient affordability initiative.

Read the source article at Aktien
2021-07-14 06:00:00